2026 NPPES data Dermatology Physician NPI 1790792851 MD
Verify on CMS →

MARK GAUGHAN, MD

Dermatology Physician in DURANGO, Colorado. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 444 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
92%
generic claims · 8% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
82.2101/100
▼ 1 pts below national avg 83.1 · [object Object]
Industry payments
$491.47
20 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MARK GAUGHAN, MD is a Dermatology Physician ([object Object]) practicing in DURANGO, Colorado with a Medicare Part D prescribing footprint of 1K claims across 444 beneficiaries — 8% brand-name prescribing . Their CMS MIPS Final Score of 82.2101/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $491.47 across 20 transactions are disclosed under CMS Open Payments (Sunshine Act).

What the federal data shows

MARK GAUGHAN, MD reported a CMS MIPS final score of 82.2101/100 — below the 83.1 national average — and filed 1,004 Medicare Part D claims in 2023.

82.2101/100
MIPS score · -1 vs avg
1K
Part D claims, 2023
92%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MARK GAUGHAN, MD's MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

82 39th percentile higher than 39% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). This entry sits in this band. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MARK GAUGHAN, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

MARK GAUGHAN, MD at a glance

Near national average

NPI registry status

Active

Issued 08/02/2006

NPI 1790792851

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

1,004 38% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

82.2101/100 0.8898999999999972% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Colorado

How Dermatology Physician compares to other specialties among Colorado providers

Colorado providers

Dermatology Physician share within Colorado

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Colorado

Medicare quality performance — MIPS

MARK GAUGHAN, MD's 2023 MIPS final score plotted against the Dermatology Physician national average

Near national average
MIPS Final Score
82.2101/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 82.2101/100 vs national avg 83.1

0%100%National avg83%82.2%
MIPS final score (Dermatology Physician) — 82.2101/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK GAUGHAN, MD is a Dermatology Physician provider practicing in DURANGO, Colorado, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: MD. NPI: 1790792851. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK GAUGHAN, MD appears in the CMS NPPES registry as a Dermatology Physician provider holding MD credentials at 523B SOUTH CAMINO DEL RIO, DURANGO, CO, 81303, with a listed phone of (970) 247-2970. NPI 1790792851 was issued on 08/02/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GAUGHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,004 prescription claims written by this provider, covering 444 Medicare beneficiaries and totaling roughly $702K in drug spend, split 8% brand-name and 92% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 82.2101/100 for the 2023 performance year (Quality 64.4202), compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

523B SOUTH CAMINO DEL RIO
DURANGO, CO 81303

Provider Details

NPI 1790792851
Specialty Dermatology Physician
Credentials MD
Gender Male
NPI Issued 08/02/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

82.2101
Final Score
Avg: 83.1
64.4202
Quality

Reporting: Group practice

Hospital and facility affiliations

Facilities where MARK GAUGHAN, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DURANGO DERMATOLOGY AND DERMATOLOGIC SURGERY LLC
DURANGO, CO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MARK GAUGHAN, MD. Source: openpaymentsdata.cms.gov.

Total received

$491

Largest payer

ABBVIE INC.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Generic-heavy

MARK GAUGHAN, MD — brand share 8.0%
Specialty average (est.)

8% brand-name claims vs 92% generic, on 1,004 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,004
Total Claims
$702K
Total Drug Cost
444
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,220
Total Day Supply
30,074
Brand vs Generic
8% brand / 92% generic
Brand Drug Cost
$670K
Generic Drug Cost
$32K
Antibiotic Claims
119

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
0.97
Gender Split
47% female / 53% male
Age Distribution
<65: 11, 65-74: 207, 75-84: 162, 85+: 64

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Triamcinolone Acetonide
171
Clobetasol Propionate
98
Doxycycline Hyclate
77
Fluorouracil
75
Acyclovir
55
Hydroxyzine Hcl
55
Ketoconazole
55
Mupirocin
39
Cephalexin
37
Prednisone
37

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How MARK GAUGHAN, MD fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

MARK GAUGHAN, MD's 1,004 claims are above the specialty average of 729.

Nearby Dermatology Physician Providers in Colorado

Other clinicians with the same primary specialty enrolled in Colorado, drawn from the same CMS NPPES roster as GAUGHAN.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK GAUGHAN, MD's specialty?
MARK GAUGHAN, MD specializes in Dermatology Physician and practices in DURANGO, Colorado. Credentials: MD.
How much does MARK GAUGHAN, MD prescribe under Medicare Part D?
In 2023, MARK GAUGHAN, MD wrote 1,004 Medicare Part D claims totaling $702K in drug costs for 444 beneficiaries.
What is MARK GAUGHAN, MD's Medicare quality score?
MARK GAUGHAN, MD has a CMS MIPS Final Score of 82.2101/100 (Quality: 64.4202). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MARK GAUGHAN, MD located?
MARK GAUGHAN, MD is located at 523B SOUTH CAMINO DEL RIO, DURANGO, CO, 81303. Phone: (970) 247-2970.
What is MARK GAUGHAN, MD's NPI number?
MARK GAUGHAN, MD's National Provider Identifier (NPI) is 1790792851, issued on 08/02/2006.
Does MARK GAUGHAN, MD prescribe more brand-name or generic drugs?
MARK GAUGHAN, MD's prescribing is 8% brand-name and 92% generic drugs by claim count, with $670K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does MARK GAUGHAN, MD prescribe most often?
Based on 2023 Medicare Part D data, MARK GAUGHAN, MD's most frequently prescribed drugs include Triamcinolone Acetonide, Clobetasol Propionate, Doxycycline Hyclate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK GAUGHAN, MD accept Medicare?
MARK GAUGHAN, MD appears in CMS Medicare data with 1,004 Part D claims and 444 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK GAUGHAN, MD's credentials?
MARK GAUGHAN, MD's NPI is 1790792851 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology